He [Albermarle CEO Luke Kissam] reserves his highest hopes for Albemarle’s fine chemistry business, which sells a variety of brominated compounds and provides custom manufacturing to pharmaceutical, agrochemical, and specialty materials customers. There, he is betting on 18% annual growth through 2015.
Albemarle is confident that coal-fired power plants will adopt its brominated activated carbon to meet coming limits on mercury emissions. In custom manufacturing, Kissam thinks he can continue to deliver 25% growth by focusing on customers that require complex or multistep syntheses and are willing to sign long-term contracts.Brominated activated carbon? That's so cool.